Neurocrine Biosciences, Inc. today announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an ...

Accomplished physician-scientist brings more than 20 years of industry leadership experience and broad R&D expertise in multiple therapeutic areas SAN DIEGO, April 4, 2025 /PRNewswire/ ...

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, released its fourth quarter financial results ...

Lexaria Bioscience (LEXX) announced that dosing has begun as scheduled in its human study GLP-1-H25-5 that is comparing oral ...

Biosciences announced the appointment of Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical ...

In addition to job gains, local leaders see Arizona emerging as one of the nation’s most dynamic hubs for bioscience ...

The institutional investor owned 99,139 shares of the company’s stock after selling 21,967 shares during the period. Prudential Financial Inc.’s holdings in Twist Bioscience were worth $ ...

Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today reported financial results for the year ...

The webcast will be archived in the same section of the company's website and available for replay until April 14, 2025. Daré Bioscience is a biopharmaceutical company driven by a mission to challenge ...

SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...

The fund owned 37,478 shares of the company’s stock after purchasing an additional 15,352 shares during the quarter. Intech Investment Management LLC’s holdings in Caribou Biosciences were ...